tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Astria Therapeutics, Inc. (DE:2090)
:2090
Germany Market
2090
Astria Therapeutics
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Astria Therapeutics (2090) Stock News & Sentiment

Compare
1 Followers
Astria Therapeutics Advances Clinical Trials and Financials
Premium
Company Announcements
Astria Therapeutics Advances Clinical Trials and Financials
4h ago
ATXS
Astria Therapeutics: Promising Developments and Strategic Advancements Justify Buy Rating
Premium
Ratings
Astria Therapeutics: Promising Developments and Strategic Advancements Justify Buy Rating
11h ago
ATXS
Astria Therapeutics: Promising Pipeline and Strong Financials Drive Buy Rating
Premium
Ratings
Astria Therapeutics: Promising Pipeline and Strong Financials Drive Buy Rating
16h ago
ATXS
Buy Rating for Astria Therapeutics: Promising Clinical Advancements and Strong Financial Position
Premium
Ratings
Buy Rating for Astria Therapeutics: Promising Clinical Advancements and Strong Financial Position
17h ago
ATXS
Astria Therapeutics, Inc. (ATXS) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Astria Therapeutics, Inc. (ATXS) Q4 Earnings Cheat Sheet
8d ago
ATXS
Promising Trial Results and Growth Potential Justify Buy Rating for Astria Therapeutics
Premium
Ratings
Promising Trial Results and Growth Potential Justify Buy Rating for Astria Therapeutics
9d ago
ATXS
Astria Therapeutics Unveils Phase 3 Trial for Navenibart
Premium
Company Announcements
Astria Therapeutics Unveils Phase 3 Trial for Navenibart
2M ago
8K
ATXS
More DE:2090 News >

2090 News on the Web

TD Cowen Remains a Buy on Astria Therapeutics (ATXS)
TipRanks News
Neutral
Analysts Are Bullish on These Healthcare Stocks: Astria Therapeutics (ATXS), uniQure (QURE)
TipRanks News
Neutral
Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema
Yahoo Finance
Neutral
Astria Therapeutics to Present at Upcoming TD Cowen 45th Annual Health Care Conference
Yahoo Finance
Neutral
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress
Yahoo Finance
Neutral
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo Finance
Neutral
Astria Therapeutics to Present at Upcoming Oppenheimer 35th Annual Healthcare Life Sciences Conference
Yahoo Finance
Neutral
Buy Rating for Astria Therapeutics: Promising Prospects in HAE and Atopic Dermatitis Markets
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:2090
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average53%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:2090’s Media Buzz Sentiment?
Currently, no data Available
What is DE:2090’s weekly average amount of articles?
Currently, no data Available
What is DE:2090’s News Sentiment?
59% of articles about DE:2090 were positive this week, compared to its sector average of 53%.
    Healthcare Stocks that are Trending in the News
    FENCFennec Pharmaceuticals
    CKPTCheckpoint Therapeutics
    CSBTFKuros Biosciences
    PTGXProtagonist Therapeutics
    SNOASonoma Pharmaceuticals
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing